Therapeutic Effect of Bone Marrow Mesenchymal Stem Cells on Rat Bladder Cancer
Download PDF
$currentUrl="http://$_SERVER[HTTP_HOST]$_SERVER[REQUEST_URI]"

Keywords

Bone marrow
Stem cells
Bladder cancer

DOI

10.26689/par.v6i6.4495

Submitted : 2022-10-18
Accepted : 2022-11-02
Published : 2022-11-17

Abstract

Objective: To analyze the effect of bone marrow mesenchymal stem cell therapy on rats with bladder cancer and provide a feasible direction for the treatment of human bladder cancer. Methods: An animal model was constructed, and Model 1 was used as an example. Two groups of rats were injected with anti-upconversion nanoparticles (UCNPs) (experimental group) and 0.9% normal saline (control group), respectively. In vivo imaging was performed to determine the accuracy of the anti-UCNPs method. Results: There were 15 rats in the experimental group with obvious bladder swelling. Among them, 11 rats had cauliflower-like and partially brown bladder tumors, whereas the other four rats had hard, nodular-like protrusions, with indistinct borders and adhesions to the anterior wall of the rectum. Small papillary masses were observed in two rats, local mucosal thickening without tumor formation was observed in two rats, and bladder stones were observed in six rats. The bladder specimens of 15 rats in the control group were pink and shiny, without any tumors. Fourteen rats in the experimental group and 12 rats in the control group had bladder cancer lesions, accounting for 93.33% and 80%, respectively. The detection accuracy of the experimental group was significantly better than that of the control group. Conclusion: Multimodal nanoprobes targeting bladder cancer stem cells in vivo were used to image the orthotopic tumor and lymph node metastasis models of animals by anti-UCNPs imaging to observe the distribution, migration, and differentiation process of bladder cancer stem cells in model mice. It is clear that rare earth upconversion luminescent nanomaterials, modified by BCMab1 and CD44 monoclonal antibodies, can be used as probes for the detection of bladder cancer, the tracking of lymph node metastasis in bladder cancer, and the comprehensive evaluation of the overall efficacy of nanoprobe-targeted therapy for bladder cancer stem cells.

References

Li B, Jiang C, Liu Z, 2022, Baicalin Regulates Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells Through EBF3 Gene. Chinese Journal of Gerontology, 42(10): 2456–2459.

Gao J, 2022, The Mechanism of Circular RNA circRBM23 Regulating Osteogenic and Adipogenic Differentiation of Bone Marrow Mesenchymal Stem Cells, thesis, Southern Medical University.

Huang Z, Liu JM, 2022, Exploring the Regulatory Mechanism of miRNA Markers in the Process of Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells. System Medicine, 7(10): 12–14 + 18.

Su M, Wang X, Zhang J, et al., 2022, Nanocellular Vesicles Loaded with Curcumin Promotes Wound Healing in Diabetic Mice. Chinese Tissue Engineering Research, 27(12): 1877–1883.

Liu R, 2021, The Role of Human Urine-Derived Mesenchymal Stem Cells on the Malignant Progression of Bladder Cancer, thesis, Qingdao University.

Wang Q, 2021, Multi-Omics to Explore the Metabolic Reprogramming Mechanism of Bladder Cancer Stem Cell-Like Cells, thesis, Kunming Medical University.

Du H, Pang X, Yang Y, et al., 2021, Expression of Tbx3 in Bladder Cancer and Its Effect on Cancer Stem Cell-Like Cells. Sichuan Medicine, 42(04): 342–345.

Cai H, 201, miR-9-3p Downregulates ESM1 in Bone Marrow Mesenchymal Stem Cell-Derived Exosomes to Inhibit the Malignant Progression of Bladder Cancer, thesis, Nanjing Medical University.

Cheng S, 2021, The Effect of Fatty Acid Oxidation Inhibitor Etomoxir on Bladder Cancer, thesis, Wuhan University.

Chen J, Liao C, Chen Z, et al., 2021, Bladder Cancer Stem Cell Markers and Related Signaling Pathways: The Idea of Antibody-Targeted Therapy. Chinese Tissue Engineering Research, 25(19): 3090–3096.

Chen Y, Luan T, Wang J, et al., 2020, Research Progress on the Origin and Stemness Maintenance Mechanism of Bladder Cancer Stem Cells. Chinese Journal of Experimental Surgery, 37(12): 2350–2354.

West China Hospital of Sichuan University, 2020, Revealing the Tumor Microenvironment-Induced Tumorigenic Mechanism of Bladder Cancer Stem Cells. China Medical Information Bulletin, 35(19): 11.

Liu A, 2020, The Mechanism of Long Non-Coding Rnan387265’s Competitive Binding to miRNA-608 to Regulate NF-kb Signaling Pathway and Affect Bladder Cancer Progression, thesis, Chinese People’s Liberation Army Naval Medical University.

Li S, Jiang T, Ma T, 2020, The Role and Mechanism of CXCR2 in the Proliferation, Apoptosis, Invasion and Metastasis of Bladder Cancer Stem Cells. Shandong Medicine, 60(14): 17–20.

Zheng R, Xu M, Xia W, et al., 2019, Comparison of Cell Origin in Invasive and Non-Invasive Bladder Cancer. Chinese Journal of Experimental Surgery, 2019(09): 1622–1625.

Xu C, Xu Z, Feng S, et al., 2019, GR Pathway Inhibits and Upregulates Tumor Stemness of Bladder Cancer. Proceedings of the 2019 Zhejiang Medical Association Urology and Andrology Academic Conference, 199–200.

Liang Z, Tao H, Guo W, et al., 2019, Smoke Promotes the Self-Renewal and Stemness Gene Expression of Bladder Cancer Stem Cells. Journal of Jiangsu University (Medical Edition), 29(03): 205–207.

Wen Y, Li Q, 2019, Therapeutic Effect of Bone Marrow Mesenchymal Stem Cells on Rat Bladder Cancer. Chinese Journal of Immunology, 35(03): 320–324.

Tan Q, 2018, Study on the Antitumor Effect of Macrophage Polarization and Evaluation of Atezolizumab Immunotherapy in Humanized Bladder Cancer Mouse Tumor Model, thesis, Guangzhou University of Traditional Chinese Medicine.